Hereditary Cancer Screening
is a critical tool for individuals
who may have a genetic predisposition
to some of the most common
and potentially life-threatening cancers

The genetic variants identified by Breakthrough Genomics’s gene panel tests can help doctors:

  • determine a patient’s risk for cancers and other health conditions
  • inform further screening and lifestyle recommendations
  • develop a treatment or management plan as needed
  • notify close family members who may also be at risk

Breakthrough Genomics’s FOCUS PANEL

Covers the 48 genes most commonly associated with high and moderate risk for specific cancers, including:
Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Melanoma, Colorectal cancer, Gastrointestinal Cancer, Leukemia, Prostrate Cancer and many others.

Breakthrough Genomics’s

Covers 145 genes including the 48 genes in the FOCUS PANEL plus nearly 100 additional genes that may also carry risk of hereditary cancer. This test maximizes the chances of indentifying potentially pathogenic variants across a wider range of genetic loci where research into cancer susceptibility is ongoing.

For a list of specific genes covered in each panel, turnaround times and sample requirements, please contact us at:

All Breakthrough Genomic tests are supported by individualized genetic counseling, best-in-class privacy protection, and an easy-to-use interface for patients and partners.

Genetic Analysis Software in USA